NO20002154L - Nye heterocykliske substituerte alfa-hydroksykarboksylsyre- derivater - Google Patents
Nye heterocykliske substituerte alfa-hydroksykarboksylsyre- derivaterInfo
- Publication number
- NO20002154L NO20002154L NO20002154A NO20002154A NO20002154L NO 20002154 L NO20002154 L NO 20002154L NO 20002154 A NO20002154 A NO 20002154A NO 20002154 A NO20002154 A NO 20002154A NO 20002154 L NO20002154 L NO 20002154L
- Authority
- NO
- Norway
- Prior art keywords
- acid derivatives
- hydroxycarboxylic acid
- heterocyclic substituted
- novel heterocyclic
- substituted alpha
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/38—One oxygen atom attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19750529A DE19750529A1 (de) | 1997-11-14 | 1997-11-14 | Neue heterocyclisch substituierte alpha-Hydroxycarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
| PCT/EP1998/007026 WO1999025701A1 (de) | 1997-11-14 | 1998-11-04 | NEUE HETEROCYCLISCH SUBSTITUIERTE α-HYDROXYCARBONSÄUREDERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS ENDOTHELINREZEPTORANTAGONISTEN |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20002154D0 NO20002154D0 (no) | 2000-04-27 |
| NO20002154L true NO20002154L (no) | 2000-05-12 |
Family
ID=7848772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20002154A NO20002154L (no) | 1997-11-14 | 2000-04-27 | Nye heterocykliske substituerte alfa-hydroksykarboksylsyre- derivater |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6358983B1 (xx) |
| EP (1) | EP1037883A1 (xx) |
| JP (1) | JP2001523671A (xx) |
| KR (1) | KR20010032083A (xx) |
| CN (1) | CN1278805A (xx) |
| AR (1) | AR017581A1 (xx) |
| AU (1) | AU752165B2 (xx) |
| BG (1) | BG104400A (xx) |
| BR (1) | BR9814157A (xx) |
| CA (1) | CA2308746A1 (xx) |
| CO (1) | CO4990973A1 (xx) |
| DE (1) | DE19750529A1 (xx) |
| HR (1) | HRP980591A2 (xx) |
| HU (1) | HUP0004341A3 (xx) |
| ID (1) | ID24819A (xx) |
| IL (1) | IL135461A0 (xx) |
| NO (1) | NO20002154L (xx) |
| NZ (1) | NZ504289A (xx) |
| PL (1) | PL340756A1 (xx) |
| SK (1) | SK4932000A3 (xx) |
| TR (1) | TR200001365T2 (xx) |
| WO (1) | WO1999025701A1 (xx) |
| ZA (1) | ZA9810425B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1750862T3 (pl) * | 2004-06-04 | 2011-06-30 | Teva Pharma | Kompozycja farmaceutyczna zawierająca irbesartan |
| MY146830A (en) * | 2005-02-11 | 2012-09-28 | Novartis Ag | Combination of organic compounds |
| US7790770B2 (en) * | 2005-11-23 | 2010-09-07 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19533023B4 (de) * | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
-
1997
- 1997-11-14 DE DE19750529A patent/DE19750529A1/de not_active Withdrawn
-
1998
- 1998-11-04 KR KR1020007005207A patent/KR20010032083A/ko not_active Application Discontinuation
- 1998-11-04 NZ NZ504289A patent/NZ504289A/en unknown
- 1998-11-04 SK SK493-2000A patent/SK4932000A3/sk unknown
- 1998-11-04 HU HU0004341A patent/HUP0004341A3/hu unknown
- 1998-11-04 EP EP98958900A patent/EP1037883A1/de not_active Withdrawn
- 1998-11-04 TR TR2000/01365T patent/TR200001365T2/xx unknown
- 1998-11-04 PL PL98340756A patent/PL340756A1/xx not_active Application Discontinuation
- 1998-11-04 ID IDW20000882A patent/ID24819A/id unknown
- 1998-11-04 CA CA002308746A patent/CA2308746A1/en not_active Abandoned
- 1998-11-04 WO PCT/EP1998/007026 patent/WO1999025701A1/de not_active Application Discontinuation
- 1998-11-04 AU AU14878/99A patent/AU752165B2/en not_active Ceased
- 1998-11-04 BR BR9814157-0A patent/BR9814157A/pt not_active IP Right Cessation
- 1998-11-04 US US09/530,382 patent/US6358983B1/en not_active Expired - Fee Related
- 1998-11-04 CN CN98811085A patent/CN1278805A/zh active Pending
- 1998-11-04 IL IL13546198A patent/IL135461A0/xx unknown
- 1998-11-04 JP JP2000521084A patent/JP2001523671A/ja active Pending
- 1998-11-09 AR ARP980105651A patent/AR017581A1/es not_active Application Discontinuation
- 1998-11-13 CO CO98067231A patent/CO4990973A1/es unknown
- 1998-11-13 HR HR19750529.5A patent/HRP980591A2/hr not_active Application Discontinuation
- 1998-11-13 ZA ZA9810425A patent/ZA9810425B/xx unknown
-
2000
- 2000-04-27 NO NO20002154A patent/NO20002154L/no not_active Application Discontinuation
- 2000-05-04 BG BG104400A patent/BG104400A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR200001365T2 (tr) | 2000-09-21 |
| HUP0004341A3 (en) | 2001-12-28 |
| US6358983B1 (en) | 2002-03-19 |
| BR9814157A (pt) | 2000-10-03 |
| DE19750529A1 (de) | 1999-05-20 |
| SK4932000A3 (en) | 2001-02-12 |
| CO4990973A1 (es) | 2000-12-26 |
| KR20010032083A (ko) | 2001-04-16 |
| HUP0004341A1 (hu) | 2001-10-28 |
| NO20002154D0 (no) | 2000-04-27 |
| NZ504289A (en) | 2002-03-01 |
| EP1037883A1 (de) | 2000-09-27 |
| AR017581A1 (es) | 2001-09-12 |
| JP2001523671A (ja) | 2001-11-27 |
| CA2308746A1 (en) | 1999-05-27 |
| AU1487899A (en) | 1999-06-07 |
| HRP980591A2 (en) | 1999-08-31 |
| BG104400A (en) | 2001-01-31 |
| AU752165B2 (en) | 2002-09-05 |
| PL340756A1 (en) | 2001-02-26 |
| ZA9810425B (en) | 2000-05-15 |
| ID24819A (id) | 2000-08-24 |
| IL135461A0 (en) | 2001-05-20 |
| WO1999025701A1 (de) | 1999-05-27 |
| CN1278805A (zh) | 2001-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0687268T3 (da) | Spiroazacykliske derivater som substans P-antagonister | |
| DK0894084T3 (da) | Kanelsyrederivater og deres anvendelse som integrinantagonister | |
| PT1007523E (pt) | Derivados indole e 2,3-di-ridroindole, sua preparacao e utilizacao | |
| TR200101155T2 (tr) | 4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III | |
| NO991761L (no) | Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse | |
| NO20052520L (no) | Nye sulfamider | |
| NO992770L (no) | Nye heterocyklisk substituerte benzamider og deres anvendelse ved bekjempelse av sykdommer | |
| EA200200510A1 (ru) | 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр | |
| YU30902A (sh) | Novi ciklopropani kao cgrp antagonisti, lekovi koji sadrže navedena jedinjenja i postupak za njihovu proizvodnju | |
| NO20001483L (no) | Nye NPY-agonister | |
| NO962855L (no) | Nye piperidin-derivater med PAF-antagonist-aktivitet | |
| NO20054225L (no) | Benzamid-derivater som oksytocin-agonister og vasopressin-antagonister | |
| NO984861L (no) | Piperidiner og pyrrolidiner | |
| NO20002124L (no) | Nye karboksylsyrederivater med amid-sidekjeder, deres fremstilling og anvendelse som endothelin-reseptorantagonister | |
| NO20012544L (no) | Substituerte benzo[de]isokinolin-1,3-dioner | |
| RS20060072A (xx) | Derivati aminokvinolina i njihova upotreba kao veznika a3 adenozina | |
| SE9903290D0 (sv) | Novel compounds | |
| NO20002154L (no) | Nye heterocykliske substituerte alfa-hydroksykarboksylsyre- derivater | |
| TR199901416T2 (xx) | Heterosiklik karbonikasit t�revleri. | |
| TR200001080T2 (tr) | 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri | |
| NO20001077L (no) | Nye karboksylsyrederivater, deres fremstilling og anvendelse som blandete ETA/ETB-endothelin-reseptorantagonister | |
| BG104022A (en) | New beta-amino and beta-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor antagonists | |
| NO20004075L (no) | Substituerte pyrimidin-2-yloksy-karboksylsyrederivater, fremstilling av disse og deres anvendelse som endotelin- antagonister | |
| NO20021502L (no) | Kinazolinoner | |
| NO20010622L (no) | Nye karboksylsyrederivater som bærer keto-sidekjeder, deres fremstilling og deres anvendelse som endotelinreseptor- antagonister |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |